期刊文献+

老年慢性收缩性心力衰竭患者远期预后的影响因素 被引量:4

Factors of the long-term prognosis in elderly patients with chronic systolic heart failure
原文传递
导出
摘要 目的:分析老年慢性收缩性心力衰竭患者远期生存情况及影响因素。方法:本研究为单中心回顾性研究。316例经超声心动图证实左室射血分数(LVEF)≤45%的缺血性心肌病和扩张型心肌病的老年患者,分为LVEF≤35%(152例)和LVEF 36%~45%(164例)两组,中位随访时间31(8~61)个月。研究终点为全因死亡。结果:共有112例死亡。LVEF≤35%的患者全因死亡率为49%,而LVEF 36%~45%的患者全因死亡率为23%(P〈0.01)。多因素COX回归分析显示,年龄、BMI、血尿酸及LVEF 4个因素对老年慢性收缩性心力衰竭患者的全因死亡率有影响(HR分别为1.050、0.573、1.002及0.968,95%CI分别为1.019~1.083、0.435~0.756、1.001~1.003及0.944~0.992,各指标P〈0.05)。结论:老年慢性收缩性心力衰竭的预后很差,特别是LVEF≤35%的患者。老年、低BMI、高尿酸血症、低LVEF是影响老年心力衰竭患者生存的独立危险因素。 Objective:To analyze the long-term situation and the impact of factors in elderly patients with chro- nic systolic heart failure. Method:This study was a single center retrospective study. The 316 cases with left ven- tricular ejection fraction (LVEF)≤45% in isehemie cardiomyopathy or dilated cardiomyopathy were divided into two groups: LVEF≤35% (n= 152) and LVEF 36%--45% (n= 164) group. Patients were followed up for a median of 31 months (8--61 months). The study endpoint was all-cause death. Result:A total of 112 cases was dead. All-cause mortality was 49% in LVEF≤35% group, and23% in LVEF36%--45% group (P(0.01). A Cox regression analysis showed that the predictors of all-cause mortality were age, BMI, uric acid and LVEF in elderly patients with chronic systolic heart failure (HR 1. 083, 0. 435--0. 756, 1. 001--1. 003 and 0. 944--0 were 1. 050, 0. 573, 1. 002 and 0. 968, 95%CI were 1. 019- 992, P〈0.05). Conclusion: Elderly patients with chronic sys tolic heart failure have a poor prognosis, especially for patients with LVEF ≤35%. Age, low BMI, high uric acid and low I.VEF are independent risk factors impacting the survival in elderly patients with heart failure.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2013年第9期683-686,共4页 Journal of Clinical Cardiology
关键词 心力衰竭 老年 预后 体重 heart failure elderly prognosis weight
  • 相关文献

参考文献13

  • 1KNIGHT E L, GLYNN R J, MCINTYRE K M, et al. Predictors of decreased renal function in patients with heart failure during angiotensin-converting en-zyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD)[J] Am Heart J, 1999,138:849-855. 被引量:1
  • 2PETRIE M C, BERRY C, ing aging hearts[J]. Eur 1990. STEWART S, et al. Fail Heart J, 2001,22: 1978-. 被引量:1
  • 3BI.ACKI.EDGE H M, TOMLINSON J, SQUIRE I B. Prognosis for patients newly admired to hospital with heart failure: survival trench in 12 220 index admissions in Leicestershire 1993-2001[J]. Heart,2003,89:615 620. 被引量:1
  • 4KALANTAR ZADEH K, BI.OCK G, HORWICH T, et al. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure[J]. Am Coil Cardiol,2004,43: 1439 1444. 被引量:1
  • 5KENCHA1AH S, EVANS J C, LEVY D, et al. O- besity and the risk of heart failure[J] N Engl J Med, 2002,347:305-313. 被引量:1
  • 6华倚虹,吴娜琼,鲁向锋,谢高强,张健,顾东风,杨跃进.体质指数与收缩性心力衰竭预后的相关性[J].中华心血管病杂志,2009,37(10):870-874. 被引量:10
  • 7PAULUS W J. Cytokines and heart failure[J]. Heart Fail Monit, 2000,1 : 50- 56. 被引量:1
  • 8FELDMAN A M, COMBES A, WANGNER D, et al. The role of tumor necrosis factor in the patho physiology of heart failure [J]. Am Coll Cardiol,2005,45:156-158. 被引量:1
  • 9WEBER M A, NEUTEL J M, SMITH D H. Con trasting clinical properties and exercise responses in obese and lean hypertensive patients[J]. Am Coil Cardiol, 2001,37 : 169-174. 被引量:1
  • 10HAMAGUCHI S, TSUCHIHASHI-MAKAYA M, KINU- GAWA S. Body mass index is an independent predictor of lo1~g-term outcomes in patients hospitalized with heart failure in Japan[J]. Circ J,2010,74:2605-2611. 被引量:1

二级参考文献44

  • 1王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008.1746-1759. 被引量:10
  • 2卫生部心血管病防治研究中心.2005年中国心血管病报告.北京:中国大百科全书出版社,2006:1-4. 被引量:1
  • 3Lavie C J, Osman AF, Milani RV, et al. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol, 2003, 91:891-894. 被引量:1
  • 4Curtis JP, Selter JG, Wang Y, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med, 2005, 165:55-61. 被引量:1
  • 5Kalantar-Zadeh K, Block G, Horwich T, et al. Reverse epidemiology of conventional cardiovascular risk factors in patients with ehrortic heart failure. J Am Coll Cardiol, 2004, 43: 1439- 1444. 被引量:1
  • 6Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation, 2005, 112 : 1756-1762. 被引量:1
  • 7Kenchaiah S, Pocock S J, Wang D, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart Failure : assessment of reduction in mortality and morbidity (CHARM) program. Circulation, 2007, 116 : 627- 636. 被引量:1
  • 8Cicoira M, Maggioni AP, Latini R, et al. Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial. Eur J Heart Fail, 2007, 9:397- 402. 被引量:1
  • 9Berry C, Clark AL. Catabolism in chronic heart failure. Eur Heart J, 2000, 21:521-532. 被引量:1
  • 10Anker SD, Ranchhaus M. Insights into the pathogenesis of chronic heart failure: immune activation and cachexia. Curr Opin Cardiol, 1999, 14: 211-216. 被引量:1

共引文献33

同被引文献38

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部